Literature DB >> 34556527

Radioembolization Versus Bland or Chemoembolization for Liver-Dominant Neuroendocrine Tumors: Is it an Either/Or Question?

Jonathan R Strosberg1, Ghassan El-Haddad2, Taymeyah Al-Toubah1, Diane Reidy3, Etay Ziv4, Armeen Mahvash5, Arvind Dasari5, Philip Philip6, Michael C Soulen7.   

Abstract

Entities:  

Keywords:  Gastrointestinal; Neuroendocrine; Neuroendocrine tumors; Radiopharmaceuticals; liver metastases; transarterial chemoembolization; transarterial embolization; transarterial radioembolization

Year:  2021        PMID： 34556527      PMCID： PMC8612204          DOI： 10.2967/jnumed.121.263041

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   11.082


× No keyword cloud information.
  23 in total

1.  Chemoembolization practice patterns and technical methods among interventional radiologists: results of an online survey.

Authors:  Ron C Gaba
Journal:  AJR Am J Roentgenol       Date:  2012-03       Impact factor: 3.959

2.  Quantitative Measurements of Enhancement on Preprocedure Triphasic CT Can Predict Response of Colorectal Liver Metastases to Radioembolization.

Authors:  F Edward Boas; Lynn A Brody; Joseph P Erinjeri; Hooman Yarmohammadi; Waleed Shady; Sirish Kishore; Constantinos T Sofocleous
Journal:  AJR Am J Roentgenol       Date:  2016-06-01       Impact factor: 3.959

3.  Radioembolization-Induced Chronic Hepatotoxicity: A Single-Center Cohort Analysis.

Authors:  Brian M Currie; Maarouf A Hoteit; Edgar Ben-Josef; Gregory J Nadolski; Michael C Soulen
Journal:  J Vasc Interv Radiol       Date:  2019-07-26       Impact factor: 3.464

4.  The role of tumor vascularity in predicting survival after yttrium-90 radioembolization for liver metastases.

Authors:  Kent T Sato; Reed A Omary; Christopher Takehana; Saad Ibrahim; Robert J Lewandowski; Robert K Ryu; Riad Salem
Journal:  J Vasc Interv Radiol       Date:  2009-10-20       Impact factor: 3.464

5.  Ki67 score as a potential predictor in the selection of liver-directed therapies for metastatic neuroendocrine tumors: a single institutional experience.

Authors:  Smit Singla; Charles M LeVea; Venkata K Pokuri; Kristopher M Attwood; Michael M Wach; Garin M Tomaszewski; Boris Kuvshinoff; Renuka Iyer
Journal:  J Gastrointest Oncol       Date:  2016-06

6.  Long-Term Hepatotoxicity of Yttrium-90 Radioembolization as Treatment of Metastatic Neuroendocrine Tumor to the Liver.

Authors:  Yu-Kai Su; Rosewell V Mackey; Ahsun Riaz; Vanessa L Gates; Al B Benson; Frank H Miller; Vahid Yaghmai; Ahmed Gabr; Riad Salem; Robert J Lewandowski
Journal:  J Vasc Interv Radiol       Date:  2017-06-30       Impact factor: 3.464

7.  Treatment of carcinoid liver metastases by hepatic-artery embolisation.

Authors:  D J Allison; I M Modlin; W J Jenkins
Journal:  Lancet       Date:  1977 Dec 24-31       Impact factor: 79.321

8.  NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018.

Authors:  Manisha H Shah; Whitney S Goldner; Thorvardur R Halfdanarson; Emily Bergsland; Jordan D Berlin; Daniel Halperin; Jennifer Chan; Matthew H Kulke; Al B Benson; Lawrence S Blaszkowsky; Jennifer Eads; Paul F Engstrom; Paul Fanta; Thomas Giordano; Jin He; Martin J Heslin; Gregory P Kalemkerian; Fouad Kandeel; Sajid A Khan; Wajih Zaheer Kidwai; Pamela L Kunz; Boris W Kuvshinoff; Christopher Lieu; Venu G Pillarisetty; Leonard Saltz; Julie Ann Sosa; Jonathan R Strosberg; Craig A Sussman; Nikolaos A Trikalinos; Nataliya A Uboha; Jonathan Whisenant; Terence Wong; James C Yao; Jennifer L Burns; Ndiya Ogba; Griselda Zuccarino-Catania
Journal:  J Natl Compr Canc Netw       Date:  2018-06       Impact factor: 11.908

Review 9.  Role of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET-Liver-Metastases Consensus Conference.

Authors:  Andrew Kennedy; Lourens Bester; Riad Salem; Ricky A Sharma; Rowan W Parks; Philippe Ruszniewski
Journal:  HPB (Oxford)       Date:  2014-09-04       Impact factor: 3.647

Review 10.  Molecular Mechanisms of Radiation-Induced Cancer Cell Death: A Primer.

Authors:  Joseph Sia; Radoslaw Szmyd; Eric Hau; Harriet E Gee
Journal:  Front Cell Dev Biol       Date:  2020-02-13
View more
  1 in total

Review 1.  Neuroendocrine Tumors and Peptide Receptor Radionuclide Therapy: When Is the Right Time?

Authors:  Thomas A Hope; Marianne Pavel; Emily K Bergsland
Journal:  J Clin Oncol       Date:  2022-06-01       Impact factor: 50.717
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.